-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Sionna Therapeutics with Buy Rating, Announces Price Target of $32

Benzinga·03/04/2025 17:39:44
Listen to the news
Stifel analyst Paul Matteis initiates coverage on Sionna Therapeutics (NASDAQ:SION) with a Buy rating and announces Price Target of $32.